What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Pulmonary hypertension
Olivier Sitbon spends much of his time researching Pulmonary hypertension, Internal medicine, Cardiology, Respiratory disease and Surgery.
The various areas that Olivier Sitbon examines in his Pulmonary hypertension study include Hemodynamics, Anesthesia, Endothelin receptor antagonist, Pathology and Pulmonary artery.
His biological study deals with issues like Intensive care, which deal with fields such as Blood pressure.
He has included themes like Prospective cohort study and Vascular disease in his Cardiology study.
His study in Respiratory disease is interdisciplinary in nature, drawing from both Germline mutation, Endocrinology, Gastroenterology, Cardiac index and Pulmonary wedge pressure.
His Surgery research is multidisciplinary, incorporating perspectives in Pharmacotherapy, Cohort study and Cohort.
His most cited work include:
- Pulmonary arterial hypertension in France: results from a national registry. (1450 citations)
- Treatment of Pulmonary Arterial Hypertension (1430 citations)
- Inhaled iloprost for severe pulmonary hypertension. (1413 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Pulmonary hypertension, Cardiology, Hemodynamics and Surgery.
His work on Vascular resistance, Pulmonary artery and Cardiac index as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
His study looks at the relationship between Pulmonary hypertension and topics such as Intensive care medicine, which overlap with Combination therapy.
His research in Cardiology intersects with topics in Bosentan, Portopulmonary hypertension and Blood pressure.
His study looks at the relationship between Bosentan and fields such as Endothelin receptor antagonist, as well as how they intersect with chemical problems.
Olivier Sitbon combines Surgery and Associated Pulmonary Arterial Hypertension in his studies.
He most often published in these fields:
- Internal medicine (88.12%)
- Pulmonary hypertension (75.22%)
- Cardiology (53.70%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (88.12%)
- Pulmonary hypertension (75.22%)
- Cardiology (53.70%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Pulmonary hypertension, Cardiology, Vascular resistance and Hemodynamics.
His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
His Pulmonary hypertension research is multidisciplinary, relying on both Blood pressure, Vascular disease, Pulmonary function testing, Interstitial lung disease and Pulmonary embolism.
His research investigates the connection between Cardiology and topics such as Walk distance that intersect with issues in Balloon.
His Vascular resistance research also works with subjects such as
- Retrospective cohort study together with Anemia,
- Lung most often made with reference to Angioplasty.
His biological study spans a wide range of topics, including Central venous pressure, Endarterectomy, Vascular remodelling in the embryo and Predictive value of tests.
Between 2017 and 2021, his most popular works were:
- Clinical trial design and new therapies for pulmonary arterial hypertension. (59 citations)
- Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality. (45 citations)
- French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (36 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Internal medicine, Pulmonary hypertension, Cardiology, Hemodynamics and Vascular resistance are his primary areas of study.
His study in Internal medicine concentrates on Hazard ratio, Randomized controlled trial, Selexipag, Lung transplantation and Macitentan.
His Pulmonary hypertension study combines topics from a wide range of disciplines, such as Right ventricular ejection fraction, Dynamic hyperinflation, Lung volumes, Interstitial lung disease and Transplantation.
His Cardiology study incorporates themes from Prospective cohort study and Inspiratory Capacity.
His study in Hemodynamics is interdisciplinary in nature, drawing from both Endarterectomy, Right ventricular dysfunction, Risk stratification and Intensive care medicine.
In his study, Whole blood, Exchange transfusion and Anemia is strongly linked to Retrospective cohort study, which falls under the umbrella field of Vascular resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
